AstraZeneca and Daiichi Sankyo win U.S. approval for breast cancer drug
AstraZeneca and Daiichi Sankyo won U.S. approval for a novel breast cancer treatment, a milestone in the companies’ efforts to turn the medicine into a widely used blockbuster. The Food and Drug Administration approved the drug for patients with advanced …